Featured Publications
Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands
Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE. Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands. Cerebrovascular And Brain Metabolism Reviews 2007, 27: 1533-1539. PMID: 17519979, DOI: 10.1038/sj.jcbfm.9600493.Peer-Reviewed Original ResearchConceptsConsensus nomenclaturePharmacokinetic modelingVivo molecular imagingRadioligandMolecular imagingVivo imagingInternational groupImaging
2013
MO‐D‐141‐01: Quantification of Tumor Hypoxia Using [18F]‐Fluoromisonidazole Positron Emission Tomography and Tracer Kinetic Modeling
Kelada O, Rockwell S, Carson R, Decker R, Oelfke U, Carlson D. MO‐D‐141‐01: Quantification of Tumor Hypoxia Using [18F]‐Fluoromisonidazole Positron Emission Tomography and Tracer Kinetic Modeling. Medical Physics 2013, 40: 399-399. DOI: 10.1118/1.4815248.Peer-Reviewed Original ResearchPositron emission tomographyBlood ratioComputed tomographyFluoromisonidazole positron emission tomographyMale BALB/c miceEmission tomographyTumor hypoxiaBALB/c miceEMT-6 tumorsNon-invasive imaging methodVoxel basisTreatment failureC miceConventional tumorHypoxia quantificationHypoxic fractionAnaesthetized animalsTumorsHistologic sectionsPharmacokinetic modelPharmacokinetic modelingDynamic positron emission tomographyPET imagingHypoxic radioresistanceBetter delineation